NASDAQ : MDAI

Spectral AI, Inc.

$1.585 USD

-$0.12 (-7.31%)

Volume
198.41K
Average Volume
506.91K
Market Capitalization
$50.44M
P/E Ratio
-4.54
Dividend Yield
0.00%
Price Target
$4.00
Year High
$2.97
Year Low
$1.18
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$0.90
Company Overview

NASDAQ

Vincent S. Capone

Medical - Specialties

Healthcare

MDAI

65

US

USD

972-499-4934

84757T105

0001833498

Liquidity Metrics

-1.35

0.90

0.85

0.70

0.00

Sales & Valuation

$19.65M

3.33

-4.22

-3.92

-0.40

Profitability

-$0.29

-$7.57M

-69.27%

-68.47%

120.69%

-54.01%

P/E Metrics

-4.54

0.07

0.07

Analyst Price Target & Rating

$4.00

$4.00

$4.00

Sell

2/5

2 Analysts

-60.38%

Financial Health Scores

-4.81

1/9

-$2.08M

$19.44M

$31.49M

-$11.4M

Key Metrics (TTM)

$56.7M

3.74

-5.14

0.90

120.69%

-325.50%

-19.14%

-23.66%

-9 days

Company Executives
Name Title
Wensheng Fan Co-Founder, Chief Innovation Strategist & Senior Advisor to the Chief Executive Officer
John Michael DiMaio Founder & Chairman
Louis Percoco General Manager
Vincent Stanley Capone CEO & Corporate Secretary
David McGuire Chief Financial Officer
Allison Kumar Head of Regulatory Affairs & Clinical Trials
Stan Micek Chief Operating Officer
Poll Results

No votes yet today — be the first to share your view!

About Spectral AI, Inc. (NASDAQ:MDAI) Stock

Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation; and delivers a binary prediction on the wounds capacity to heal or not heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient’s wounds. Its system also includes MSI imaging technology, which consists of proprietary multi-spectral optics and sensors that capture injured tissue images; and AI-Burn software. Spectral AI, ... Inc. is headquartered in Dallas, Texas.

Spectral AI, Inc. (MDAI) Q2 2026 Earnings Call Transcript

2026-08-11 23:47:09

Spectral AI, Inc. (MDAI) Q2 2026 Earnings Call Transcript

Spectral AI Q2 Earnings Call Highlights

2026-08-11 19:05:47

Spectral AI NASDAQ: MDAI said its second-quarter results marked a transition toward commercial operations following the U.S. Food and Drug Administration's De Novo clearance of its DeepView System for burn assessment in May. The company reiterated its 2026 revenue guidance of approximately $18.5 million, which does not assume significant revenue from DeepView system sales.

Spectral AI Announces 2026 Second Quarter Financial Results

2026-08-11 16:05:00

Company Continues to Advance Towards First Commercial Sales of the DeepView® System for Burn Indication Strong Cash Position of $14.0 Million at June 30, 2026 DALLAS, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced financial results for the second quarter ended June 30, 2026 (“Q2 2026”). “Spectral AI has entered the second half of 2026 with tremendous momentum and a clear sense of purpose,” said Vincent Capone, Chief Executive Officer of Spectral AI.

Spectral AI Schedules 2026 Second Quarter Financial Results and Conference Call

2026-07-29 16:15:00

DALLAS, July 29, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the second quarter ended June 30, 2026 on Tuesday, August 11, 2026, after the close of the Nasdaq stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time on the same day to discuss its financial results.

Spectral AI Names Darcy Bajko Chief Commercial Officer to Lead Global Sales Launch of FDA-Cleared DeepView® System for Burn Indication

2026-07-08 08:30:00

Industry Veteran Brings Two Decades of Experience Driving Growth Through New Product Launches, Training and Education Industry Veteran Brings Two Decades of Experience Driving Growth Through New Product Launches, Training and Education

DeepView® System Highlighted at the 2026 British Burn Association Annual Conference

2026-06-25 08:30:00

DALLAS, June 25, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today reflected on its successful participation at the British Burn Association (BBA) Annual Conference, held on June 17th – 19th  at the Nottingham Trent University, Nottingham, England.    The Company's DeepView® System was on display and was the subject of multiple podium and poster presentations during the conference, highlighting its contributions to advancing burn care through advanced diagnostic analysis across the globe.

Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month

2026-06-12 08:30:00

DALLAS, June 12, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, is joining the American Board of Wound Management (ABWM) Foundation in celebrating the 10th Annual Wound Healing Awareness Month.

Spectral AI to Participate in 2026 British Burn Association Annual Conference

2026-06-11 08:30:00

Company Will Showcase FDA-Cleared DeepView® System for Burn Indication Company Will Showcase FDA-Cleared DeepView® System for Burn Indication

Frequently Asked Questions

What is the current Spectral AI, Inc. (MDAI) stock price?

Spectral AI, Inc.(NASDAQ:MDAI) stock price is $1.585 in the last trading session. During the trading session, MDAI stock reached the peak price of $2.97 while $1.18 was the lowest point it dropped to. The percentage change in MDAI stock occurred in the recent session was --7.31% while the dollar amount for the price change in MDAI stock was -$0.12.

MDAI's industry and sector of operation?

The NASDAQ listed MDAI is part of Medical - Specialties industry that operates in the broader Healthcare sector.

Who are the executives of MDAI?

Wensheng Fan | Co-Founder, Chief Innovation Strategist & Senior Advisor to the Chief Executive Officer
John Michael DiMaio | Founder & Chairman
Louis Percoco | General Manager
Vincent Stanley Capone | CEO & Corporate Secretary
David McGuire | Chief Financial Officer

How many employees does MDAI have?

Number of MDAI employees currently stands at 65. MDAI operates from 2515 McKinney Avenue, Dallas, TX 75201, US.

Link for MDAI official website?

Official Website of MDAI is: https://www.spectral-ai.com

How do I contact MDAI?

MDAI could be contacted at phone #972-499-4934 and can also be accessed through its website. MDAI operates from 2515 McKinney Avenue, Dallas, TX 75201, US.

How many shares of MDAI are traded daily?

The average number of MDAI shares traded daily for last 3 months was 506.91K.

What is the market cap of MDAI currently?

The market value of MDAI currently stands at $50.44M with its latest stock price at $1.585